Recall Record

Hyderabad, N/A, India

Hetero Labs, Ltd. - Unit III recalls

4 recalls recorded since 2018, most recently on 12 September 2018. None are listed as ongoing. Status and classification are as published by the FDA.

Recalls4
Ongoing (FDA)0
Terminated or completed4
Class I (FDA)0

Terminated Class III Drugs

Recall started
12 September 2018
Terminated
29 November 2018
Reason
Presence of Foreign Tablet/Capsule: A foreign identified as Valacyclovir tablet 500 mg was co-mingled in a bottle containing Fenofibrate Tablets, USP 145 mg.
Distribution
Indiana and Louisiana
Initiated
Voluntary: Firm initiated
Recall number
D-1211-2018

Terminated Class II Drugs

Recall started
18 July 2018
Terminated
15 July 2021
Reason
Failed Tablet/Capsule Specifications: customer complaints of deformed, clumped, misshaped, melted or stuck together capsules.
Distribution
Nationwide in the USA
Initiated
Voluntary: Firm initiated
Recall number
D-1019-2018

Terminated Class II Drugs

Recall started
10 January 2018
Terminated
21 September 2020
Reason
CGMP Deviations: lot made with active pharmaceutical ingredient that did not meet all its intended specifications.
Distribution
NJ Only
Initiated
Voluntary: Firm initiated
Recall number
D-0594-2018

Terminated Class III Drugs

Recall started
22 December 2017
Terminated
23 March 2018
Reason
Presence of foreign substance: metallic razor blade was found in one bottle.
Distribution
U.S.A. nationwide
Initiated
Voluntary: Firm initiated
Recall number
D-0223-2018

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.